Roxana Cabrera-Brown, MD
Family Practice · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 5 years
- Graduated 2021
Offices
3 locations · Community Medical Centers, Inc. · 47 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Cabrera-Brown’s office to ask if they take your plan before you enroll.
Medicaid work
$7,859 in 2024
Medicaid paid $7,859 for 52 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 39 | $7,859 |
| Short return visit (20+ min) | 13 | $0 |
| 2024 | 52 | 2 | 23 | $7,859 |
| 2023 | 81 | 3 | 34 | $11,391 |
| 2022 | 16 | 1 | 16 | $3,862 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 47 | $11,391 |
| Short return visit (20+ min) | 16 | $0 |
| Return visit (30+ min) | 18 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 16 | $3,862 |
Drugs they prescribed that Part D paid
$15,326
Pharmacies billed $15,326 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
186 generic and fewer than 11 brand-name prescriptions · $15,326 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 17 | $129 | $8 |
| Metformin | 21 | $93 | $4 |
| Losartan | 21 | $74 | $4 |
| Lisinopril | 13 | $67 | $5 |
| Amlodipine Besylate | 16 | $32 | $2 |
Year by year
| 2024 | 201 | 45 | None | None | $15,326 |
| 2023 | 374 | 65 | None | None | $43,642 |
| 2022 | 182 | 37 | None | 15% | $22,908 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Atorvastatin | 30 | $926 | $31 |
| Losartan | 20 | $459 | $23 |
| Amlodipine Besylate | 41 | $415 | $10 |
| Diclofenac | 12 | $412 | $34 |
| Metformin | 21 | $346 | $16 |
| Lisinopril | 14 | $183 | $13 |
2022: 4 drugs
| Atorvastatin | 11 | $161 | $15 |
| Lisinopril | 13 | $160 | $12 |
| Metformin | 15 | $146 | $10 |
| Losartan | 12 | $97 | $8 |
Money from drug and device companies
$109 in 2025
A payment is not proof that care is biased.
| Lilly USA | Zepbound | $109 | 1 payment
|
See the published payment
| Lilly USA | Meals · 2025-09-17 | Zepbound | $109 |
Professional record
- NPI
- 1225673106
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 701 E Channel St, Stockton, CA, 95202
- NPI first listed
- 2019-11-14
- NPI last updated
- 2024-10-23
- NPI record certified
- 2024-10-23
This is when the NPI record was last certified, not a medical board exam.